Liver Metastases
256
54
71
92
Key Insights
Highlights
Success Rate
81% trial completion
Published Results
25 trials with published results (10%)
Research Maturity
92 completed trials (36% of total)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 52/100
8.2%
21 terminated out of 256 trials
81.4%
-5.1% vs benchmark
10%
26 trials in Phase 3/4
27%
25 of 92 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 92 completed trials
Clinical Trials (256)
SAMe in Prevention of Oxaliplatin-associated Liver Injury
Hepzato Kit and Opdualag for Metastatic Melanoma and Liver Metastasis
Neoadjuvant Dupilumab and Toripalimab in MSS CRC Subjects With Resectable Liver Metastases
Outcomes After Liver and Biliary Resection at a High-Volume Center
Incremental Value of Magnetic Resonance Imaging in Selection of Pancreatic Cancer Patients for Surgery
Comparison of Contrast Agents in Liver Magnetic Resonance (MR) for the Detection of Hepatic Metastases
Neoadjuvant Serplulimab & Bevacizumab With FOLFOX vs. FOLFOX Alone in RAS/BRAF WT, pMMR/MSS CRC Patients
Platform Study of Immunotherapy Combinations in Colorectal Cancer Liver Metastases
Stereotactic Body Radiation Therapy (SBRT) Efficiency and Toxicity in Liver Cancer
Tissue Analysis After Tumor Ablation for Liver Metastases Leading to Immediate Retreatment
Histotripsy Plus Chemotherapy vs Chemotherapy Alone for Advanced Colorectal Liver Metastasis
Microwave Ablation Versus Stereotactic Body Radiotherapy for Colorectal Liver Metastases in Oligometastatic Disease: a Prospective, Randomised, Phase 2 Trial
An Open-Label, Single-Arm, Dose-Escalation Phase I Study Evaluating the Safety, Tolerability, and Preliminary Efficacy of EDB-102 in Patients With EGFR L858R-Mutant, Third-Generation TKI-Resistant Advanced Non-Small Cell Lung Cancer With Liver Metastases
Lesion Detection Assessment in the Liver: Standard vs Low Radiation Dose Using Varied Post-Processing Techniques
An Exploratory Study of Atezolizumab and Bevacizumab in Hepatocellular Carcinoma and Non-Small Cell Lung Cancer With Liver Metastases (INTEGRATE)
The MOMENTUM Study: The Multiple Outcome Evaluation of Radiation Therapy Using the MR-Linac Study
Ultra-high Dose Radiation for Liver Metastasis Using MR-guided TReatment With Stereotactic Ablative Single-fraction
EUS-guided CTCs + Multi-omics: Predicting Pancreatic Cancer Recurrence and Metastases
Promoting Immunotherapy Efficacy With Low-Dose Liver RT
A Study of QBECO Versus Placebo in the Treatment of Colorectal Cancer That Has Spread to the Liver